China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; and other dosage forms, including pills and tablets; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, chronic illnesses, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, China. China Shineway Pharmaceutical Group Limited operates as a subsidiary of Forway Investment Limited.
Frequently asked questions
What sector does China Shineway Pharmaceutical Group Limited (CSWYF) operate in?
China Shineway Pharmaceutical Group Limited belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is China Shineway Pharmaceutical Group Limited (CSWYF) current stock price?
As of the latest data, China Shineway Pharmaceutical Group Limited stock price is $1.00, with a previous close of $1.00.
What is China Shineway Pharmaceutical Group Limited (CSWYF) current market capitalization?
China Shineway Pharmaceutical Group Limited market cap is approximately 758.42 million.
What is China Shineway Pharmaceutical Group Limited (CSWYF) Earnings Per Share (EPS)?
The trailing EPS is $0.20.
What is China Shineway Pharmaceutical Group Limited (CSWYF) Price-to-Earnings (P/E) ratio?
China Shineway Pharmaceutical Group Limited current P/E ratio is 5.02.
Does China Shineway Pharmaceutical Group Limited (CSWYF) pay dividends?
Yes. China Shineway Pharmaceutical Group Limited pays other dividends with an annualized yield of 30.68% and an estimated annual payout of $0.31 per share.
When is the next ex-dividend date for China Shineway Pharmaceutical Group Limited (CSWYF)?
The next ex-dividend date is scheduled for October 06, 2026.
What is China Shineway Pharmaceutical Group Limited (CSWYF) beta (volatility) score?
China Shineway Pharmaceutical Group Limited has a beta of 0.678, indicating lower volatility than the overall market.
